Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Open accessThe DOI matches its Crossref record; 235 of the 237 references it cites were found in a registry or an index.
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
The cited source says what the claim attributes to it.
In the citing paper
“In the human vasculature, the most relevant isoforms appear to be NOX1, NOX2, NOX4, and NOX5 (252, 253, 555).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Drummond et al., 2011
In the citing paper
“NOXs are multiprotein enzyme complexes that catalyze the electron transfer to molecular oxygen to form ROS, more commonly superoxide, but also hydrogen peroxide (79, 252, 383, 546, 912).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 1×
“As vascular NADPH oxidases, especially NOX2 oxidase, are similar in structure to the phagocytic NADPH oxidase (see below and Ref”
BackgroundNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 1×
“NOX2 oxidase in phagocytic cells was the first member of the NADPH oxidase family to be identifie”
BackgroundAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationRole of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624 · cited 1×
“Oxidative stress not only causes direct and irreversible oxidative damage to macromolecules but also disrupts key redox-dependent signalling processes in the arterial wal”
BackgroundSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400 · cited 1×
“This nullifies the anti-inflammatory and vasodilator functions of NO, and promotes the formation of peroxynitrit”
BackgroundPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134 · cited 1×
“Peroxynitrite is a powerful oxidant in its own right, and may thus contribute to oxidative stress through oxidation of small-molecule antioxidants such as glutathione, cysteine and tetrahydro—biopteri”
BackgroundSegal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789 · cited 1×
“NOX2 oxidase-expressing leukocytes classically comprise cells of the innate immune system — that is, neutrophils, monocytes and macrophage”
BackgroundRole of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 1×
“NOX2 oxidase activity in circulating T lymphocytes is increased in experimental hypertensio”
BackgroundChronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Research works printed but not linked: 1
- Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304–13313 (2011). · DOI · Paper page
Cited by
Items 201–300 of 900
Spescha, R. D., Klohs, J., Semerano, A., Giacalone, G., Derungs, R. S., Reiner, M. F., Rodriguez Gutierrez, D., Mendez-Carmona, N., Glanzmann, M., Savarese, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv140 · Cited by 76
Chan, S.-H., Hung, C.-H., Shih, J.-Y., Chu, P.-M., Cheng, Y.-H., Lin, H.-C., Hsieh, P.-L., & Tsai, K.-L. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.016 · Cited by 76
“NADPH oxidases are multi-subunit enzyme complexes that generate ROS from molecular oxygen using NADPH as the electron donor [25].”
BackgroundEffects of angiotensin II on the cerebral circulation: role of oxidative stress
De Silva, T. M., & Faraci, F. M. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00484 · Cited by 74
“In the vasculature in general, it is believed that Nox1, Nox2, and Nox4 are expressed in endothelial cells, Nox1 and Nox4 are expressed in smooth muscle cells and Nox2 and Nox4 expressed in adventitia (Drummond et al., 2011).”
BackgroundMethionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress
Suzuki, S., Kodera, Y., Saito, T., Fujimoto, K., Momozono, A., Hayashi, A., Kamata, Y., & Shichiri, M. (2016) · Scientific Reports · doi:10.1038/srep38299 · Cited by 75
Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging
Mladenov, M. I., Lubomirov, L. T., Grisk, O., Avtanski, D. B., Mitrokhin, V. M., Sazdova, I., Keremidarska‐Markova, M., Danailova, Y., Nikolaev, G., Konakchieva, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12051126 · Cited by 82
Gatto, G. J., Ao, Z., Kearse, M. G., Zhou, M., Morales, C. R., Daniels, E., Bradley, B. T., Goserud, M. T., Goodman, K. B., Douglas, S. A., et al. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.636360 · Cited by 73
Shafique, E., Torina, A. G., Reichert, K., Colantuono, B. J., Nur, N., Zeeshan, K., Ravichandran, V. S., Liu, Y., Feng, J., Zeeshan, K., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw249 · Cited by 75
Opportunity Nox: The Future of NADPH Oxidases as Therapeutic Targets in Cardiovascular Disease
Streeter, J., Thiel, W. H., Brieger, K., & Miller, F. J. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00310.x · Cited by 76
Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension
Ateş, İ., Özkayar, N., İnan, B., Yılmaz, F. M., Topçuoğlu, C., Neşeli̇oğlu, S., Erel, Ö., Dede, F., & Yılmaz, N. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.12.008 · Cited by 71
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 77
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
Martin-Ventura, J., Rodrigues-Diez, R., Martinez-Lopez, D., Salaices, M., Blanco-Colio, L., & Briones, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112315 · Cited by 69
“MPO is a hemoprotein mainly released by activated leukocytes that catalyzes the reaction between H2O2 and chloride ions to produce HOCl as the primary oxidant.”
BackgroundInfluentialOxidative Stress and the Role of NADPH Oxidase in Glaucoma
Gaskin, J. C. F., Shah, M. H., & Chan, E. C. (2021) · Antioxidants · doi:10.3390/antiox10020238 · Cited by 87
Glutathione Peroxidase-1 Reduces Influenza A Virus–Induced Lung Inflammation
Yatmaz, S., Seow, H. J., Gualano, R. C., Wong, Z. X., Stambas, J., Selemidis, S., Crack, P. J., Bozinovski, S., Anderson, G. P., & Vlahos, R. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0345oc · Cited by 70
Self-citationVara, D. S., Campanella, M., & Pula, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02130.x · Cited by 70
“In view of the recent development of novel and selective NOX inhibitors (Drummond et al., 2011), our observations open new possibilities for the development of novel antithrombotic treatments that target NOX1.”
BackgroundOrganizers and activators: Cytosolic Nox proteins impacting on vascular function
Schröder, K., Weißmann, N., & Brandes, R. P. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.017 · Cited by 81
“Based on the concept that ROS are potential harmful molecules, NADPH oxidases have been a pharmacological target since long [133].”
Robson, R., Kundur, A., & Singh, I. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.12.029 · Cited by 82
Dual oxidase: a novel therapeutic target in allergic disease
van der Vliet, A., Danyal, K., & Heppner, D. E. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14158 · Cited by 78
“Current status of development of NOX inhibitors The growing appreciation of specific role(s) of individual NOX enzymes in various biological and pathological contexts has spurred various efforts to develop isoform-specific inhibitors of NOX enzymes (Drummond et al., 2011; Gatto et al., 2013; Altenhofer et al., 2015; C…”
BackgroundLuo, M., Tian, R., Yang, Z., Peng, Y., & Lu, N. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.06.007 · Cited by 75
Nox1 Oxidase Suppresses Influenza A Virus-Induced Lung Inflammation and Oxidative Stress
Selemidis, S., Seow, H. J., Broughton, B. R. S., Vinh, A., Bozinovski, S., Sobey, C. G., Drummond, G. R., & Vlahos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060792 · Cited by 70
“superoxide [20,21].”
Self-citationKim, H. A., Miller, A. A., Drummond, G. R., Thrift, A. G., Arumugam, T. V., Phan, T. G., Srikanth, V. K., & Sobey, C. G. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0790-7 · Cited by 72
“While clinical therapeutic strategies aimed to enhance endogenous antioxidant levels in patients with vascular disease have failed to reduce clinical cardiovascular events, in retrospect it appears that such an approach to neutralise excess levels of ROS was ineffective due to their extremely rapid reactions with impo…”
BackgroundInfluentialSelf-citationTranscriptional regulation of Nox4 by histone deacetylases in human endothelial cells
Siuda, D., Zechner, U., Hajj, N. E., Prawitt, D., Langer, D. J., Xia, N., Horke, S., Pautz, A., Kleinert, H., Förstermann, U., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0283-3 · Cited by 75
“Oxidative stress is associated with all known cardiovascular risk factors, and a large body of evidence indicates that it is implicated in many of the processes of atherogenesis [9, 39].”
BackgroundNADPH Oxidase as a Therapeutic Target for Oxalate Induced Injury in Kidneys
Joshi, S. K., Peck, A. B., & Khan, S. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/462361 · Cited by 71
Mangiferin modulation of metabolism and metabolic syndrome
Fomenko, E. V., & Chi, Y. (2016) · BioFactors · doi:10.1002/biof.1309 · Cited by 68
Redox control of vascular smooth muscle cell function and plasticity
Durgin, B. G., & Straub, A. C. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0032-9 · Cited by 74
“NOX1, NOX4, and NOX5 isoforms are present within SMC [29, 30].”
InfluentialDu, J., Fan, L. M., Mai, A., & Li, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12336 · Cited by 67
“On the other hand, even when it is fully activated, total endothelial Nox2 activity is only about 1% of that in the neutrophils (Drummond et al., 2011).”
BackgroundMitigation of NADPH Oxidase 2 Activity as a Strategy to Inhibit Peroxynitrite Formation
Zielonka, J., Zielonka, M., VerPlank, L., Cheng, G., Hardy, M., Ouari, O., Ayhan, M. M., Podsiadły, R., Sikora, A., Lambeth, J. D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702787 · Cited by 68
“For example, inflammatory lung diseases include acute respiratory distress syndrome, asthma, and chronic obstructive pulmonary disease, although other inflammatory conditions include Alzheimer and Parkinson diseases, ischemic stroke, and organ reperfusion injury during transplantation (43).”
BackgroundHu, X., Wang, L. Q., Xiang, G., Lei, W., & Feng, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.008 · Cited by 71
Aberrant energy metabolism in Alzheimer’s disease
Yu, L., Jin, J., Xu, Y., & Zhu, X. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0024 · Cited by 71
“[93] The activation of NADPH oxidase(NOX) may also contribute to EC dysfunction.[93, 94] For example, NOX2 knockout in ECs abrogates ROS production and vascular dysfunction in AD.”
BackgroundWu, J., Tsai, H. D., Cheung, W.-M., Hsu, C. Y., & Lin, T. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9294-z · Cited by 70
The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases
Chan, T., Wilkinson‐Berka, J. L., Deliyanti, D., Hunter, D., Fung, A. T.-C., Liew, G., & White, A. J. R. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108255 · Cited by 76
Tang, Z., Hong, D., Zhang, Y., Li, G., Yu, H., Bai, S., Guo, G.-Y., Guo, W., Ma, Y., Wang, J., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303036 · Cited by 68
“Nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) is the primary enzyme that mediates ROS production (Drummond et al., 2011).”
BackgroundMeijles, D. N., Fan, L. M., Howlin, B. J., & Li, J.-M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561159 · Cited by 66
“Insight into the regulatory mechanism of NADPH oxidase activation is essential for developing novel therapeutic strategies to treat these oxidative stress-related cardiovascular diseases without affecting the neutrophil oxidative response to infection (4).”
Xiao, Q., Xiong, Z., Yu, C., Zhou, J., Shen, Q., Wang, L., Xie, X., & Fu, Z. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112699 · Cited by 70
Zhang, L. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2597-8 · Cited by 69
“…action in the vascular wall, including the production of reactive oxygen species, and activation of inflammatory mechanisms, such as inducing expression of inflammatory cytokines and adhesion molecules (Drummond et al. 2011; Mehta and Griendling 2007; Tedgui and Mallat 2006; Berk 2001).”
BackgroundNADPH Oxidase and the Cardiovascular Toxicity Associated with Smoking
Kim, M., Han, C.-H., & Lee, M. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.3.149 · Cited by 65
“Over the last two decades, several studies have suggested that the NOX family of ROS generating enzymes play crucial functions in the development of CVD (10,37).”
BackgroundLai, S., Molfino, A., Testorio, M., Perrotta, A. M., Currado, A., Pintus, G., Pietrucci, D., Unida, V., Rocca, D. L., Biocca, S., et al. (2019) · Nutrients · doi:10.3390/nu11123006 · Cited by 67
Sottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., & Cavalot, F. L. (2015) · Medicinal Research Reviews · doi:10.1002/med.21349 · Cited by 83
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Odagiri, N., Matsubara, T., Sato-Matsubara, M., Fujii, H., Enomoto, M., & Kawada, N. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0187 · Cited by 61
Current status of NADPH oxidase research in cardiovascular pharmacology
Álvarez, E., Rodiño-Janeiro, Paradela-Dobarro, Castiñeiras-Landeira, Raposeiras‐Roubín, S., & González‐Juanatey, J. R. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33053 · Cited by 78
“The main volume of research in all fields and particularly in the cardiovascular field includes NOX1, NOX2, and NOX4.”
BackgroundInfluentialVictor, P., Umapathy, D., George, L., Juttada, U., Ganesh, G. V., Amin, K. N., Viswanathan, V., & Ramkumar, K. M. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01176-z · Cited by 67
Hussain, A. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-025-00247-3 · Cited by 97
“NOX is the major source of ROS in cells such as VSMCs, endothelial cells, and fibroblasts [82].”
Becker, D., & Natarajan (2012) · Cell Health and Cytoskeleton · doi:10.2147/chc.s4955 · Cited by 70
“Downregulation of protein tyrosine phosphatase results in activation of the receptor tyrosine kinase and downstream pathways, such as extracellular signal-regulated kinase/ mitogen activated protein kinase, c-Jun N-terminal kinase, and phosphatidylinositol 3-kinase/Akt (a serine/threonine protein kinase), which regula…”
InfluentialROS production as a common mechanism of ENaC regulation by EGF, insulin, and IGF-1
Ilatovskaya, D. V., Pavlov, T. S., Levchenko, V., & Staruschenko, A. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00231.2012 · Cited by 61
Sümegi, K., Fekete, K., Antus, C., Debreceni, B., Hocsák, E., Gallyas, F., Sümegi, B., & Szabó, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169372 · Cited by 66
Li, Y., Zhou, Z.-H., Chen, M.-H., Yang, J., Leng, J., Cao, G.-S., Xin, G.-Z., Liu, L.-F., Kou, J.-P., Liu, B.-L., et al. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6479 · Cited by 61
“Although several isoforms of NADPH oxidase express in the vessel endothelium, accumulating evidence demonstrates the crucial role of NOX2 oxidase in endothelial injury (9).”
Oxidative Stress in Diabetes Mellitus and the Role Of Vitamins with Antioxidant Actions
Lazo-de-la-Vega-Monroy, M.-L., & Fernndez-Mej, C. (2013) · InTech eBooks · doi:10.5772/51788 · Cited by 97
“It is the only enzyme whose primary function is generating superoxide and/or hydrogen peroxide, mainly for preventing the transfer of pathogens and for cellular bactericidal function[12, 13].”
BackgroundAl-Magableh, M., Kemp‐Harper, B. K., Ng, H. H., Miller, A. A., & Hart, J. L. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0920-x · Cited by 60
“This family of enzymes compromises two membrane-bound subunits, the NADPH oxidase catalytic subunit and p22phox as well as various combinations of cytoplasmic subunits (Drummond et al. 2011).”
BackgroundXu, G., Zhang, J., Pan, H., Tian, S., Liu, M., Yu, T., Li, J., Ying, W.-W., Yao, W., Lin, X.-H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2349 · Cited by 61
Gliemann, L., Nyberg, M., & Hellsten, Y. (2013) · Free Radical Research · doi:10.3109/10715762.2013.835045 · Cited by 69
Finckenberg, P., Eriksson, O., Baumann, M., Merasto, S., Lalowski, M. M., Levijoki, J., Haasio, K., Kytö, V., Muller, D. N., Luft, F. C., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.179457 · Cited by 60
Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Yang, B., & Chen, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6545728 · Cited by 64
Nocella, C., D’Amico, A., Cammisotto, V., Bartimoccia, S., Castellani, V., Loffredo, L., Marini, L., Ferrara, G., Testa, M., Motta, G., et al. (2023) · Antioxidants · doi:10.3390/antiox12020429 · Cited by 67
“Therefore, for clinical purposes, NOX2 represents a potential target to develop novel isoform-selective drugs to prevent or treat cardiovascular diseases [104].”
BackgroundKotla, S., Singh, N. K., Heckle, M., Tigyi, G., & Rao, G. N. (2013) · Science Signaling · doi:10.1126/scisignal.2004214 · Cited by 65
Friederich‐Persson, M., Cat, A. N. D., Persson, P., Montezano, A. C. I., & Touyz, R. M. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308659 · Cited by 61
“characterized, including Nox1, Nox2, Nox3, Nox4, and Nox5 and the dual oxidases 1 and 2.(35) Nox4 is the predominant iso-”
BackgroundMolecular insights of NADPH oxidases and its pathological consequences
Waghela, B. N., Vaidya, F. U., Agrawal, Y., Santra, M. K., Mishra, V., & Pathak, C. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3589 · Cited by 66
Antioxidants for prostate cancer chemoprevention: Challenges and opportunities
Thapa, D., & Ghosh, R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.027 · Cited by 62
“However, given that conventional antioxidants exhibit poor reactivity with many endogenous ROS [98], we speculate that antioxidants may be unable to achieve clinical efficacy.”
BackgroundZhou, S., Li, W., Shi, F., Zhou, Z.-W., Li, B., Zhang, K., Zhang, X., Ouyang, C., & Zhu, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s85426 · Cited by 61
Justo, M. L., Candiracci, M., Dantas, A. P., de Sotomayor, M. Á., Parrado, J., Vila, E., Herrera, M. D., & Rodríguez‐Rodríguez, R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.004 · Cited by 65
“Vascular function impairment in the metabolic syndrome mainly implies an unbalance between the vasoprotective effect of endothelial nitric oxide (NO) and the unfavorable action of vasoconstrictor factors [e.g., endothelin-1 and reactive oxygen species (ROS)] and proinflammatory mediators [e.g. tumor necrosis factor (T…”
BackgroundInfluentialInterleukin-10 protects against aging-induced endothelial dysfunction
Kinzenbaw, D. A., Chu, Y., Peña Silva, R. A., Didion, S. P., & Faraci, F. M. (2013) · Physiological Reports · doi:10.1002/phy2.149 · Cited by 57
“A prominent source of superoxide in vascular cells is NADPH oxidase (Drummond et al. 2011).”
BackgroundBruder-Nascimento, T. B., Chinnasamy, P., Riascos‐Bernal, D. F., Cáu, S. B. D. A., Callera, G. E., Touyz, R. M., Tostes, R. C., & Sibinga, N. E. S. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.10.013 · Cited by 58
“This event triggers oxygen reduction leading to superoxide anion formation [28,29].”
BackgroundHemoglobin Control of Cell Survival/Death Decision Regulates in Vitro Plant Embryogenesis
Huang, S., Hill, R. D., Wally, O. S. D., Dionisio, G., Ayele, B. T., Jami, S. K., & Stasolla, C. (2014) · PLANT PHYSIOLOGY · doi:10.1104/pp.114.239335 · Cited by 68
“The NADPH oxidase inhibitors AEBSF and DPI were applied at concentrations of 1 mM and 5 mM, respectively (Diatchuk et al., 1997; Drummond et al., 2011; Ryder et al., 2013).”
MethodLai, C., Shao, J.-S., Behrmann, A., Krchma, K., Cheng, S., & Towler, D. A. (2012) · Endocrinology · doi:10.1210/en.2012-1216 · Cited by 68
NADPH Oxidases as Novel Pharmacologic Targets against Influenza A Virus Infection
Vlahos, R., & Selemidis, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095216 · Cited by 61
“Unlike NOX2 and NOX1, which produce superoxide and then H2O2 after dismutation of superoxide by SOD, NOX4, DUOX1, and DUOX2 enzymes generate H2O2 directly (Drummond et al., 2011).”
BackgroundSelf-citationDeveloping a biomimetic tooth bud model
Smith, E. E., Zhang, W., Schiele, N. R., Khademhosseini, A., Kuo, C. K., & Yelick, P. C. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2246 · Cited by 60
“In natural tissues and organs, blood vessels are composed of a luminal endothelial cell layer, surrounded by a layer of smooth muscle cells (Melero-Martin et al., 2008; Hahn and Schwartz, 2009; Drummond et al., 2011; Chen et al., 2012).”
Backgroundde Jesus, D. S., DeVallance, E., Li, Y., Falabella, M., Guimarães, D. A., Shiva, S., Kaufman, B. A., Gladwin, M. T., & Pagano, P. J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101138 · Cited by 61
“PCR products were separated by electrophoresis through 1% agarose gels and visualized by Gel StarTM Nucleic acid gel stain [16]”
BackgroundMethodInfluentialSmall Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?
Moretti, R., & Caruso, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031095 · Cited by 65
Wang, Q., Chu, C., Oyarzabal, E., Jiang, L., Chen, S., Wilson, B., Qian, L., & Hong, J. (2014) · Glia · doi:10.1002/glia.22724 · Cited by 57
“In recent decades, a number of peptides and small, molecular compounds have been developed to inhibit NOX2 and treat inflammation-related diseases (Aldieri et al., 2008; CifuentesPagano et al., 2014; Drummond et al., 2011).”
BackgroundDurán-Prado, M., Frontiñán, J., Santiago-Mora, R., Peinado, J. R., Parrado-Fernández, C., Gómez-Almagro, M. V., Moreno, M., López-Domínguez, J. A., Villalba, J. M., & Alcaín, F. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109223 · Cited by 57
“Augmented levels of ROS are common factors in all major vascular diseases [48].”
BackgroundInhibition of NADPH Oxidase by Apocynin Attenuates Progression of Atherosclerosis
Kinkade, K. J., Streeter, J., & Miller, F. J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140817017 · Cited by 63
“Numerous studies have implicated NADPH oxidases as the primary source of superoxide in vascular disease [22,23].”
BackgroundZappe, K., Pointner, A., Switzeny, O. J., Magnet, U., Tomeva, E., Heller, J., Mare, G., Wagner, K., Knasmüller, S., & Haslberger, A. G. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3734250 · Cited by 62
“Therefore, colorectal adenocarcinoma Caco-2 cells in normoglycemic and hyperglycemic media were treated with a mixture of tocopherols and tocotrienols in combination with different doses of H2O2 as well as ROS inhibitor N-acetylcysteine (NAC) [42] and NOX inhibitor VAS2870 [43].”
MethodInfluentialLi, Y., Kong, D., Ahmad, A., Bao, B., & Sarkar, F. H. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5233 · Cited by 60
“It is known that oxidative stress is linked to aging and various chronic diseases such as atherosclerosis, neurodegenerative diseases, diabetes, pulmonary fibrosis, and arthritis, which are commonly accompanied by inflammation (12,35, 102).”
Nakagawa, T., Hasegawa, Y., Uekawa, K., Ma, M., Katayama, T., Sueta, D., Toyama, K., Kataoka, K., Koibuchi, N., Maeda, M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000375 · Cited by 56
Horinouchi, T., Higashi, T., Mazaki, Y., & Miwa, S. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00025 · Cited by 50
“27,28) NOX2 is composed of a six membrane-spanning catalytic NOX2 subunit known as gp91 phox , a two membrane-spanning p22 phox subunit, and cytosolic proteins p40 phox , p47 phox , p67 phox , RAC1, and RAC2.”
InfluentialSun, Q., Zhang, W., Zhong, W., Sun, X., & Zhou, Z. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.009 · Cited by 55
“In addition to CYP2E1 andmitochondrial electron transport chain (ETC), NADPH oxidase (NOX) is another well-known source of ROS generation [10,11].”
Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba
Ye, W., Wang, J., Little, P. J., Zou, J., Zheng, Z., Lü, J., Yin, Y., Liu, H., Zhang, D., Liu, P., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.09.014 · Cited by 62
“One central mechanism of alleviating endothelial dysfunction is decreasing the expression and/or activity of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) 60,61 , and it is expressed at a higher level than the other four members of the NOX family 65 .”
BackgroundOnodera, Y., Teramura, T., Takehara, T., & Fukuda, K. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.05.007 · Cited by 57
“Increased generation of ROS leads to acceleration of tissue injury, dysfunction and degradation by promoting cell death and ECM remodeling [23,24].”
Aguado, A., Galán, M., Zhenyukh, O., Wiggers, G. A., Roque, F. R., Redondo, S., Peçanha, F. M., Martín, Á., Fortuño, A., Cachofeiro, V., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.030 · Cited by 60
“Themajor source of ROS generated in the cardiovascular system is the NADPH oxidase (NOX) family of enzymes which is activated by a variety of stimuli (Drummond et al., 2011; Touyz et al., 2011).”
BackgroundAnalgesic activity of piracetam: Effect on cytokine production and oxidative stress
Navarro, S. A., Serafim, K. G. G., Mizokami, S. S., Hohmann, M. S., Casagrande, R., & Verri, W. A., Jr. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.02.018 · Cited by 56
Quesada, I. M., Lucero, A., Amaya, C., Meijles, D. N., Cifuentes, M. E., Pagano, P. J., & Castro, C. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.011 · Cited by 54
“In our study, we demonstrated that the administration of Nox2ds-tat to ApoE−/− mice fed a Western type diet resulted in a significantly reduced in Nox-derived superoxide in the vascular wall, with associated downregulation of the expression of membrane-bound subunit p22phox and the cytosolic p47phox, a key interaction…”
MethodRole of oxidative stress on platelet hyperreactivity during aging
Fuentes, E., & Palomo, I. F. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.026 · Cited by 59
Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Cifuentes-Pagano, M., Meijles, D., & Pagano, P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112013 · Cited by 55
Structure and function of HECT E3 ubiquitin ligases and their role in oxidative stress
Qian, H. R., Zhang, Y., Wu, B., Wu, S., You, S., Zhang, N., & Sun, Y. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0012 · Cited by 59
“on the endothelium and the proliferation and migration of vascular smooth muscle cells.[75]”
BackgroundPromising Antioxidative Effect of Berberine in Cardiovascular Diseases
An, N., Zhang, G., Li, Y., Yuan, C., Yang, F., Zhang, L., Gao, Y., & Xing, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865353 · Cited by 53
Jiang, S., Zhao, Y., Zhang, T., Lan, J., Yang, J., Yuan, L., Zhang, Q., Pan, K., & Zhang, K. (2018) · Cell Proliferation · doi:10.1111/cpr.12427 · Cited by 55
Emerging molecular mechanisms of vascular dementia
Romay, M. C., Toro, C., & Iruela‐Arispe, M. L. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000502 · Cited by 59
Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders
Signorelli, S. S., Marino, E., Scuto, S., & Raimondo, D. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124393 · Cited by 66
Targeting the Redox Landscape in Cancer Therapy
Narayanan, D., Ma, S., & Özcelik, D. (2020) · Cancers · doi:10.3390/cancers12071706 · Cited by 61
“The cytosolic subunits p47phox and NOXO1, and the activator subunits p67phox and NOXA1, are essential for NOX1 and NOX2 function [152,153].”
Ferroptosis mechanism and Alzheimer's disease
Feng, L., Sun, J. J., Xia, L., Shi, Q., Hou, Y., Zhang, L., Li, M., Fan, C., & Sun, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389362 · Cited by 61
Hwang, G. H., Ryu, J. M., Jeon, Y. J., Choi, J., Han, H. J., Lee, Y. M., Lee, S., Bae, J., Jung, J., Chang, W., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.058 · Cited by 59
Moe, K. T., Khairunnisa, K., Yin, N. O., Chin-Dusting, J. P. F., Wong, P. E. H., & Wong, M. C. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0345-0 · Cited by 56
Sharma, A. K., LaPar, D. J., Stone, M. L., Zhao, Y., Mehta, C. K., Kron, I. L., & Laubach, V. E. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1253oc · Cited by 58
Wiciński, M., Domanowska, A., Wódkiewicz, E., & Malinowski, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082749 · Cited by 57
Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges
Vong, L. B., & Nagasaki, Y. (2020) · Antioxidants · doi:10.3390/antiox9090791 · Cited by 57
“Several strategies have been attempted to improve the NO bioavailability by increasing endogenous NO synthesis [103], inhibiting the NO metabolism [104], and activating NOS systems [105].”
BackgroundQi, Y., Li, J., Nie, Q., Gao, M., Yang, Q., Li, Z., Li, Q., Han, S., Ding, J., Li, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120952 · Cited by 52
Status of Mitochondrial Oxidative Phosphorylation during the Development of Heart Failure
Bhullar, S. K., & Dhalla, N. S. (2023) · Antioxidants · doi:10.3390/antiox12111941 · Cited by 63
Hydrogen sulfide as a vasculoprotective factor
Streeter, E., Ng, H. H., & Hart, J. L. (2013) · Medical Gas Research · doi:10.1186/2045-9912-3-9 · Cited by 53
“catalytic subunit and p22phox as well as various combinations of cytoplasmic subunits [31].”
BackgroundBlanco-Menéndez, N., del Fresno, C., Fernandes, S., Calvo, E., Conde-Garrosa, R., Kerr, W. G., & Sancho, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402874 · Cited by 52
“DPI, a NADPH oxidase inhibitor (43), abolished HKC-triggered ROS generation in GM-BM (Fig.”
Nox and Inflammation in the Vascular Adventitia
Meijles, D. N., & Pagano, P. J. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.03622 · Cited by 56
“In the adventitia, Nox-derived ROS is the dominant culprit for intracellular redox signaling cascade activation, either in an autocrine or paracrine manner, leading to subsequent vascular cell activation, proliferation, hypertrophy, and apoptosis and thereby promoting vascular diseases including hypertension and ather…”
BackgroundMarques, V. B., Botelho, T., Júnior, R. F. R., Broseghini-Filho, G. B., Rossi, E. M., Graceli, J. B., & dos SANTOS, L. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.034 · Cited by 53
“It is known that hydrogen peroxide can not only be produced by the dismutation of O2 •– , which was significantly increased in the IO group, but can also be directly produced by enzymes such as NADPH oxidase [46], xanthine oxidase and glucose oxidase [47].”
Dinh, Q. N., Chrissobolis, S., Diep, H., Chan, C. T., Ferens, D. M., Drummond, G. R., & Sobey, C. G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.032 · Cited by 60
Self-citation
Metadata
- Authors
- Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G.
- Affiliations
- Monash University (AU)
- Emory University (US)
- Corresponding author
- Drummond, Grant R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06
- Volume
- 10
- Issue
- 6
- Pages
- 453-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3361719
- OpenAlex
- W1974997758
- Cited by
- 899
- References
- 237
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 35 · 2022: 51 · 2021: 66 · 2020: 69 · 2019: 55 · 2018: 63 · 2017: 77 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 88 · 2012: 71
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL38206, R01HL038206, HL095070, HL058863, R37HL038206, HL-092120, R01HL092120, P01HL095070, R01HL058863)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NADPH oxidase, NOX1, NOX2, oxidative stress, reactive oxygen species, NADPH oxidase inhibitors, p47phox, endothelial dysfunction, vascular inflammation, atherogenesis, arterial remodeling, hypertension, hypercholesterolemia, diabetes mellitus, aging, cardiovascular disease
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Animals, Antioxidants, Humans, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Vascular Diseases, Drug Delivery Systems, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.